Autologous CD34+ cells enriched with allogenic placenta-derived mitochondria
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD34+ cells enriched with allogenic placenta-derived mitochondria, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS) [Phase 2]